Zenith Healthcare Past Earnings Performance
Past criteria checks 4/6
Zenith Healthcare's earnings have been declining at an average annual rate of -9.5%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 8.1% per year. Zenith Healthcare's return on equity is 3.2%, and it has net margins of 1.8%.
Key information
-9.5%
Earnings growth rate
-10.2%
EPS growth rate
Pharmaceuticals Industry Growth | 17.5% |
Revenue growth rate | 8.1% |
Return on equity | 3.2% |
Net Margin | 1.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zenith Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 131 | 2 | 18 | 0 |
30 Sep 23 | 129 | 2 | 18 | 0 |
30 Jun 23 | 123 | 2 | 16 | 0 |
31 Mar 23 | 132 | 1 | 17 | 0 |
31 Dec 22 | 195 | 1 | 21 | 0 |
30 Jun 22 | 226 | 1 | 21 | 0 |
31 Mar 22 | 226 | 3 | 18 | 0 |
31 Dec 21 | 160 | 3 | 15 | 0 |
30 Jun 21 | 136 | 4 | 12 | 0 |
31 Mar 21 | 139 | 4 | 15 | 0 |
31 Dec 20 | 146 | 9 | 15 | 0 |
30 Sep 20 | 146 | 10 | 15 | 0 |
30 Jun 20 | 136 | 9 | 15 | 0 |
31 Mar 20 | 121 | 6 | 14 | 0 |
31 Dec 19 | 120 | 3 | 14 | 0 |
30 Sep 19 | 105 | 0 | 13 | 0 |
30 Jun 19 | 98 | 1 | 11 | 0 |
31 Mar 19 | 99 | 1 | 12 | 0 |
31 Dec 18 | 105 | 2 | 12 | 0 |
30 Sep 18 | 121 | 4 | 12 | 0 |
30 Jun 18 | 125 | 4 | 12 | 0 |
31 Mar 18 | 96 | 3 | 11 | 0 |
31 Dec 17 | 77 | 2 | 11 | 0 |
30 Sep 17 | 57 | 0 | 10 | 0 |
30 Jun 17 | 53 | -1 | 10 | 0 |
31 Mar 17 | 48 | -2 | 10 | 0 |
31 Dec 16 | 48 | -1 | 10 | 0 |
30 Sep 16 | 42 | -2 | 9 | 0 |
30 Jun 16 | 35 | -5 | 0 | 0 |
31 Mar 16 | 35 | -3 | 9 | 0 |
31 Dec 15 | 33 | -3 | 11 | 0 |
30 Sep 15 | 37 | -3 | 10 | 0 |
30 Jun 15 | 37 | -2 | 10 | 0 |
31 Mar 15 | 36 | -2 | 8 | 0 |
31 Dec 14 | 36 | -2 | 12 | 0 |
30 Sep 14 | 32 | -3 | 12 | 0 |
30 Jun 14 | 33 | -5 | 7 | 0 |
31 Mar 14 | 33 | -3 | 12 | 0 |
31 Dec 13 | 35 | -1 | 13 | 0 |
30 Sep 13 | 37 | -1 | 13 | 0 |
30 Jun 13 | 39 | 1 | 6 | 0 |
Quality Earnings: 530665 has high quality earnings.
Growing Profit Margin: 530665's current net profit margins (1.8%) are higher than last year (0.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530665's earnings have declined by 9.5% per year over the past 5 years.
Accelerating Growth: 530665's earnings growth over the past year (161.5%) exceeds its 5-year average (-9.5% per year).
Earnings vs Industry: 530665 earnings growth over the past year (161.5%) exceeded the Pharmaceuticals industry 23.1%.
Return on Equity
High ROE: 530665's Return on Equity (3.2%) is considered low.